Results 21 to 30 of about 140,847 (256)
Non-alcoholic fatty liver disease
BMJ, 2014 #### Summary points Non-alcoholic fatty liver disease (NAFLD) is now more common than alcoholic liver disease owing to the rapid rise in the prevalence of obesity,1 and NAFLD is the most common cause of abnormal liver function tests.2 Its prevalence worldwide is thought to be approximately 20% in the general population and up to 70% in patients with ...
David Preiss +2 more
openaire +4 more sources
Non-alcoholic fatty liver disease:mind the gaps: pathophysiology and non-invasive diagnosis [PDF]
, 2021 Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in western countries. Globally, NAFLD affects approximately 25% of the population. The term NAFLD includes both fatty liver disease (steatosis) and inflammation of the liver (NASH;
Verhaegh, Pauline Loraine Maria
core +2 more sources
Immunoglobulin A and liver diseases. [PDF]
, 2017 Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple functions in the gut, such as to regulate microbiota composition, to protect intestinal epithelium ...
Inamine, Tatsuo, Schnabl, Bernd
core +2 more sources
Non‐alcoholic fatty liver disease
Journal of Diabetes, 2012 AbstractNon‐alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world. It is closely associated with metabolic syndrome. The alarming epidemics of diabetes and obesity have fueled an increasing prevalence of NAFLD, particularly among these high‐risk groups.
Charissa Chang, Ana C. Tuyama
openaire +3 more sources
Heterogeneity of non‐alcoholic fatty liver disease [PDF]
Liver International, 2015 See Article on Page ...
Hannele Yki-Järvinen +3 more
openaire +3 more sources
Frequency and risk factors of non-alcoholic fatty liver disease in Helicobacter pylori-infected dyspeptic patients: A cross-sectional study [PDF]
, 2021 Background: In dyspeptic patients with Helicobacter pylori contributes to non-alcoholic fatty liver disease. However, little evidence available from Pakistan.Objective: The study aims to determine the frequency and risk factors of non-alcoholic fatty ...
Abbas, Zaigham +8 more
core +1 more source
CYTOKERATIN-18 AS A MARKER OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OBESE ADOLESCENTS [PDF]
, 2020 In parallel with the obesity epidemic in the world, the prevalence of non-alcoholic fatty liver disease among children and adolescents is growing.
Khomenko, Margaryta
core +3 more sources
Pathogenesis of non-alcoholic fatty liver disease [PDF]
QJM, 2009 Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of disease ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. The prevalence of NAFLD has risen rapidly in parallel with the dramatic rise in obesity and diabetes,1,2 and is rapidly becoming the most common cause of liver disease in ...
Dowman, Joanna K +2 more
openaire +4 more sources
The diagnosis of non‐alcoholic fatty liver disease [PDF]
Alimentary Pharmacology & Therapeutics, 2011 no ...
Isabel Ferreira +8 more
openaire +5 more sources
Non-alcoholic fatty liver disease and lipotoxicity [PDF]
Clinical and Experimental Hepatology, 2021 Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but recent literature describes this relation as much ...
Dariusz Marek Lebensztejn +1 more
openaire +2 more sources